HDAC4 blocks autophagy to trigger podocyte injury: non-epigenetic action in diabetic nephropathy

Qingqing Wei1, Zheng Dong2

  • 1Department of Cellular Biology and Anatomy, Medical College of Georgia, Georgia Regents University and Charlie Norwood Veterans Affairs Medical Center, Augusta, Georgia, USA.

Kidney International
|October 1, 2014
PubMed

Insights

Histone deacetylases (HDACs) contribute to diabetic nephropathy (DN) kidney disease. Specifically, HDAC4 damages podocytes by suppressing essential autophagy, suggesting HDAC inhibitors as potential DN therapeutics.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Histone deacetylases (HDACs) are linked to kidney disease pathogenesis, but their specific roles, particularly in diabetic nephropathy (DN), remain unclear.
  • Understanding the molecular mechanisms underlying podocyte injury in DN is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression patterns of various HDACs in diabetic nephropathy.
  • To elucidate the specific role of HDAC4 in podocyte injury during DN.
  • To determine the molecular mechanism by which HDAC4 affects podocyte function in DN.

Main Methods:

  • Analysis of HDAC expression in DN models.
  • Experimental manipulation of HDAC4 levels in podocytes.
  • Assessment of autophagy markers and STAT1 acetylation.
  • Evaluation of podocyte viability and function.

Main Results:

  • Wang et al. identified specific changes in HDAC expression profiles in DN.
  • HDAC4 was found to be a key contributor to podocyte injury in DN.
  • HDAC4 was shown to deacetylate STAT1, leading to the suppression of autophagy.
  • Suppressed autophagy was directly linked to impaired podocyte function and viability.

Conclusions:

  • HDAC4 plays a critical role in DN pathogenesis by inhibiting autophagy through STAT1 deacetylation.
  • Targeting HDAC4 or related pathways could offer a novel therapeutic strategy for DN.
  • Development of HDAC isoform-specific inhibitors may provide effective treatments for DN and other renal diseases.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
4
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
19
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
29
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
23
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K